Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Nagahashi

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
International Journal of Molecular Sciences|March 28, 2024
Targeting Sphingosine-1-Phosphate Signaling in Breast CancerMasayuki Nagahashi, Yasuo Miyoshi
Journal of Thoracic Disease|July 4, 2012
Management of massive soft tissue defects: The use of INTEGRA® artificial skin after necrotizing soft tissue infection of the chestOmar M Rashid, Masayuki Nagahashi, Kazuaki Takabe
Mediators of Inflammation|September 16, 2017
Clinical Impact of Sphingosine-1-Phosphate in Breast CancerJunko Tsuchida, Masayuki Nagahashi, Kazuaki Takabe, et al.
Lymphatic Research and Biology|September 19, 2012
The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesisTomoyoshi Aoyagi, Masayuki Nagahashi, Akimitsu Yamada, et al.
World Journal of Gastroenterology|August 24, 2010
Lymphangiogenesis: a new player in cancer progressionMasayuki Nagahashi, Subramaniam Ramachandran, Omar M Rashid, et al.
Japan Medical Association Journal : JMAJ|October 9, 2019
Do Preys Prey on Their Predators? Confusion Over Predatory "Hage-taka" JournalsKazuaki Takabe, Masayuki Nagahashi, Ali L Butash, et al.
Breast Cancer (Tokyo, Japan)|April 10, 2019
Clinical application of ceramide in cancer treatmentKazuki Moro, Masayuki Nagahashi, Emmanuel Gabriel, et al.
Breast Cancer Research and Treatment|September 21, 2023
Baseline interleukin-6 is a prognostic factor for patients with metastatic breast cancer treated with eribulinAyako Bun, Masayuki Nagahashi, Mamiko Kuroiwa, et al.
Oncotarget|January 18, 2018
Hypermutation and microsatellite instability in gastrointestinal cancersKizuki Yuza, Masayuki Nagahashi, Satoshi Watanabe, et al.
Annals of Gastroenterological Surgery|July 30, 2020
Genetic analysis in the clinical management of biliary tract cancerToshifumi Wakai, Masayuki Nagahashi, Yoshifumi Shimada, et al.
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
International Journal of Molecular Sciences|March 28, 2024
Targeting Sphingosine-1-Phosphate Signaling in Breast CancerMasayuki Nagahashi, Yasuo Miyoshi
Journal of Thoracic Disease|July 4, 2012
Management of massive soft tissue defects: The use of INTEGRA® artificial skin after necrotizing soft tissue infection of the chestOmar M Rashid, Masayuki Nagahashi, Kazuaki Takabe
Mediators of Inflammation|September 16, 2017
Clinical Impact of Sphingosine-1-Phosphate in Breast CancerJunko Tsuchida, Masayuki Nagahashi, Kazuaki Takabe, et al.
Lymphatic Research and Biology|September 19, 2012
The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesisTomoyoshi Aoyagi, Masayuki Nagahashi, Akimitsu Yamada, et al.
World Journal of Gastroenterology|August 24, 2010
Lymphangiogenesis: a new player in cancer progressionMasayuki Nagahashi, Subramaniam Ramachandran, Omar M Rashid, et al.
Japan Medical Association Journal : JMAJ|October 9, 2019
Do Preys Prey on Their Predators? Confusion Over Predatory "Hage-taka" JournalsKazuaki Takabe, Masayuki Nagahashi, Ali L Butash, et al.
Breast Cancer (Tokyo, Japan)|April 10, 2019
Clinical application of ceramide in cancer treatmentKazuki Moro, Masayuki Nagahashi, Emmanuel Gabriel, et al.
Breast Cancer Research and Treatment|September 21, 2023
Baseline interleukin-6 is a prognostic factor for patients with metastatic breast cancer treated with eribulinAyako Bun, Masayuki Nagahashi, Mamiko Kuroiwa, et al.
Oncotarget|January 18, 2018
Hypermutation and microsatellite instability in gastrointestinal cancersKizuki Yuza, Masayuki Nagahashi, Satoshi Watanabe, et al.
Annals of Gastroenterological Surgery|July 30, 2020
Genetic analysis in the clinical management of biliary tract cancerToshifumi Wakai, Masayuki Nagahashi, Yoshifumi Shimada, et al.
Pageof 21